Skip to main content

Table 2 Clinical examination at discharge

From: An operational comparative study of quinine and artesunate for the treatment of severe malaria in hospitals and health centres in the Democratic Republic of Congo: the MATIAS study

 

Quinine

Artesunate

 

2–59 months (N = 226)

>5 years (N = 144)

2–59 months (N = 208)

>5 years (N = 131)

Weight (kg)

11.1 (3.0)

32.8 (16.7)

11.2 (4.3)

27.2 (14.9)

Temperature (°C)

36.7 (0.5)

36.6 (0.5)

36.7 (0.4)

36.5 (0.4)

Pulse

100 (70–128)

90 (41–120)

90 (64–124)

85.4 (18.8)

Respiratory rate per minute

35 (22–40)

28 (16–48)

31.8 (6.6)

29.2 (8.0)

Persistence of signs at discharge

12 (5.4 %)

6 (4.3 %)

7 (3.4 %)

4 (3.0 %)

  1. Data are summarized as numbers (%), median (90 % central range) or mean (SD)